TEVA FY 2009 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena

TEVATeva Pharmaceutical Industries Limited

$35B

FY 2009 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$13.9B+25.4% YoY

Gross Profit

$7.4B53.0% margin

Operating Income

$2.4B17.3% margin

Net Income

$2.0B14.4% margin

EPS (Diluted)

$2.23

Cash Flow

Operating Cash Flow

$3.4B

Free Cash Flow

$2.7B

Stock-Based Comp.

$54M

Balance Sheet

Total Assets

$33.8B

Total Liabilities

$14.6B

Stockholders' Equity

$19.2B

Cash & Equivalents

$2.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13.9B	$11.1B	+25.4%
Gross Profit	$7.4B	$6.0B	+23.4%
Operating Income	$2.4B	$1.1B	+110.0%
Net Income	$2.0B	$635M	+215.0%